Company intelligence / Profile preview

Kudos

Boston, Massachusetts, USAkudos.com ↗

Ownership: Private
Development stage: Other

Overview

Kudo Biotechnology is a global CDMO specializing in end-to-end cGMP manufacturing solutions for mRNA therapeutics. The company offers rapid timelines from sequence to GMP product (~6.5 months), state-of-the-art facilities across three continents, and advanced quality management systems. It has successfully supported multiple client products into clinical trials and maintains strong technology partnerships to enhance process efficiency and regulatory compliance.

Modalities: mRNA-based drugsPlasmid DNA (pDNA)Lipid nanoparticle delivery therapySelf-amplifying mRNA (saRNA)ProteinsAdeno-associated virus vector therapy (AAV)
Industry: Contract Manufacturing Organization

Partnerships

Applied DNA Sciences (Linea™ IVT platform integration)

Beyond the preview

Go deeper on Kudos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kudos.

Explore the full profile